A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women

Trial Profile

A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs Conjugated estrogens/bazedoxifene (Primary) ; Itraconazole
  • Indications Atrophic vaginitis; Postmenopausal osteoporosis; Vasomotor symptoms
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 04 Apr 2016 Results presented at The 98th Annual Meeting of the Endocrine Society
    • 10 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top